Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Midway in conjunction with the acquisition of Eribel
Mandate

Vinge advises Midway in conjunction with the acquisition of Eribel

February 23, 2011

Vinge has advised Midway Holding in conjunction with the purchase of the entire issued share capital in Eribel Production AB. Eribel is a sub-contracting supplier of electronics, primarily in respect of medical and industrial equipment. The turnover for 2010 amounted to SEK 110 million with profit after financial items amounting to SEK 3.8 million. The purpose of the acquisition is to co-ordinate the operations with Onrox AB, which Midaway has owned since 2005.
Peter Oscarsson of Vinge advised Midway in conjunction with the acquisition.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026